Detalhe da pesquisa
1.
A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
Lab Invest
; 97(10): 1245-1261, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28414327
2.
CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.
Int J Cancer
; 138(8): 1971-81, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26595254
3.
FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
Mol Cancer Res
; 15(12): 1678-1691, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851816
4.
Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
Sci Rep
; 5: 14983, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26447334